Shopping Cart
- Remove All
Your shopping cart is currently empty
SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 250 mg | $185 | 35 days | |
| 500 mg | $295 | 35 days | |
| 1 g | $448 | 35 days |
| Description | SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine. |
| Synonyms | Z-Phe-chloromethylketone, ZLPhe chloromethyl ketone, Z L Phe chloromethyl ketone, NSC-251810 |
| Molecular Weight | 331.79 |
| Formula | C18H18ClNO3 |
| Cas No. | 26049-94-5 |
| Relative Density. | 1.1630 g/cm3 (Estimated) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: Soluble |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.